(Q36078073)

12 August 2017

1 reference

title

RANK, RANKL and osteoprotegerin in arthritic bone loss (English)

1 reference

12 August 2017

M C Bezerra

1

1 reference

12 August 2017

J F Carvalho

series ordinal

2

1 reference

12 August 2017

A S Prokopowitsch

series ordinal

3

1 reference

12 August 2017

R M R Pereira

series ordinal

4

1 reference

12 August 2017

language of work or name

English

0 references

publication date

15 February 2005

1 reference

Brazilian Journal of Medical and Biological Research

12 August 2017

published in

1 reference

12 August 2017

volume

38

1 reference

12 August 2017

issue

2

1 reference

12 August 2017

page(s)

161-170

1 reference

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

Osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

Pathogenesis of bone erosions in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

Role for osteoprotegerin in rheumatoid inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

RANKL and RANK as novel therapeutic targets for arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

Animal models of arthritis: relevance to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

Kinetics of bone protection by recombinant osteoprotegerin therapy in Lewis rats with adjuvant arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

Duration of bone protection by a single osteoprotegerin injection in rats with adjuvant-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

The osteoprotegerin/receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand system in cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

A revival of the B cell paradigm for rheumatoid arthritis pathogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

RANK ligand, RANK, and OPG expression in type II collagen-induced arthritis mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

A new mechanism of bone destruction in rheumatoid arthritis: synovial fibroblasts induce osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

New treatments for rheumatoid arthritis. Available and upcoming slow-acting antirheumatic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

One-year inhibition of tumor necrosis factor-alpha: a major success or a larger puzzle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

NEW MOLECULES IN THE TUMOR NECROSIS FACTOR LIGAND AND RECEPTOR SUPERFAMILIES WITH IMPORTANCE FOR PHYSIOLOGICAL AND PATHOLOGICAL BONE RESORPTION.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005000200004

10.1590/S0100-879X2005000200004

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference